Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer.
Jpn J Clin Oncol
; 49(9): 832-838, 2019 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-31070763
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Maximum Tolerated Dose
/
Hyperthermia, Induced
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Jpn J Clin Oncol
Year:
2019
Type:
Article
Affiliation country:
South Korea